I'm making drugs for cats
trevorklee.substack.com
trevorklee.substack.com
I loved that cat, she got me through grad school, and losing her was miserable. My gratitude to anyone working on stomatitis treatments.
(I'm sorry for what you and your calico endured. F cancer)
There is a perpetual movement to take words and shuffle them around as a form of purity spiraling. People who don't want to work build entire careers out of pretending moral outrage. Play their game and you give them power. Next thing you know, the words that were okay to say are verboten and you're the next one crushed under the wheel of progress.
So what? There are a hundred words your ancestors used that you never will. How has it changed your life one iota to have never uttered cockalorum, twitter-light, or grumpish?
> There is a perpetual movement to take words and shuffle them around
Yes, this has happened for all time.
No, that's a modern side effect of critical theory and grievance agitators. Nice try, though.
Words starting out as factual and neutral, then acquiring a negative connotation, then falling out of use except as insults is literally a tale as old as time.
> The word "idiot" comes from the Greek noun ἰδιώτης idiōtēs 'a private person, individual' (as opposed to the state), 'a private citizen' (as opposed to someone with a political office), 'a common man', 'a person lacking professional skill, layman', later 'unskilled', 'ignorant', derived from the adjective ἴδιος idios 'personal' (not public, not shared). In Latin, idiota was borrowed in the meaning 'uneducated', 'ignorant', 'common',[5] and in Late Latin came to mean 'crude, illiterate, ignorant'. In French, it kept the meaning of 'illiterate', 'ignorant', and added the meaning 'stupid' in the 13th century. In English, it added the meaning 'mentally deficient' in the 14th century.
> The word shit appears to have originally been a euphemism for defecation in Pre-Germanic, as the Proto-Indo-European root *sḱeyd-, from which it was derived, meant 'to cut off'.
> In the 20th century, where the old euphemisms lavatory (a place where one washes) or toilet (a place where one dresses[20]) had grown from widespread usage (e.g., in the United States) to being synonymous with the crude act they sought to deflect, they were sometimes replaced with bathroom (a place where one bathes), washroom (a place where one washes), or restroom (a place where one rests)
I never thought I’d come across a sincere call for banning all dictionaries, but… well I never thought it, it doesn’t make me surprised.
Yes, such as every major one.
Dictionaries are prescriptive. People use different words or use them in different ways over time and dictionaries update to reflect that. The only difference is how fast they update.
Dictionaries are extremely expensive to run and rarely turn a profit. Are you surprised the "major ones" will lie straight to your face and intentionally warp your perspective of the world?
People update usage over time and dictionaries reflect that. It’s extremely common and not just a modern effect.
It’s just a property of human language and it occurs in every language.
Now understand some simple fundamental realities. Dictionaries have always been expensive and almost never turned a profit in history. They were created as loss leaders for name recognition, passion projects by eccentrics, heavily subsidized by fundraising or (most often) a combination of the three. They are subject to corruption through funding, through people, and through the will of their parent company.
Merriam-Webster should be focusing on language and it's use. Not subtly accusing Kyle Rittenhouse of fake crying during trial. It's corrupted at the personally level at the very least. Not to mention their cozy relationship with Google.
Oxford, like most universities, has had biased hiring policies since my parents were children. Today, it's filled with the out of touch, weak and over-socialized. They have received a mountain of criticism regarding their "woke score" hiring policies, "woke" additions to their dictionary and many other issues.
It's unfortunate that you and others trust such biased sources. Like being "the dictionary" gives it some sort of official authority on the way you can communicate.
Personally i prefer: https://en.wiktionary.org/wiki/retard
Well the way to say that without redundance, parenthetical, and the sibling tree about whether or not it's offensive is 'it's kinda depressing/<emotion> how retarded the progress has been' (or similar).
That sounds like a Phase 1 trial for safety in human volunteers. If the plan was to sell the IP to or partner with a major Pharma, maybe this could work. But the IP situation may not be that clear-cut with a drug repurposing, especially given this:
> This is still a tall order for a guy whose background was, again, science blogger. But things went surprisingly ok, all things considered. I linked up with an excellent corporate attorney and patent attorney, both of whom agreed to let me use their services on a pay later basis. ...
You really can't do this on the cheap.
People in tech (or even science broadly) trying to get into the drug industry frankly have no clue about what it actually takes to get a drug approved for humans in the US. Hundreds of millions are table stakes. The bar is higher than just about any other industry for new product introduction, even for a repurposing.
Even if the bear market had stayed in hibernation for another year or two, the fundamental problem is that human drug approval is a massive resource drain that requires very deep pockets and an ironclad IP position.
Failure (after massive expenditure) should be considered the base case.
What would be a clever approach to make a drug viable/revenue creating?
They weigh up all their current & future pipeline almost daily in terms of risk/reward monetary values. I'm not really sure I feel a great desire to shed a tear for big pharma. They always seem to do alright when their results get posted at the end of each financial year. I've wrestled with the debate as to whether human medicine development/discovery is best done in this environment for a long time. And, I still haven't decided. Competition is good/healthy, but financial drive seems to be trumping the human/healing element more than ever.
In the last decade, it feels like they've spun most of the risks out to the small biotech startups, who they'll all get into a bidding war over once a potential product shows a vague shred of promise/monetary value. I'm not discounting the fact that the hills aren't littered with the hundreds of corpses of failed "promising" new biotechs/drugs they pumped hundreds of millions into for absolutely no return at all. I'm just not convinced the whole ecosystem is the best long-term strategy for human health. I guess that's what I'm really trying to say.
Plenty of large pharma companies have effectively disappeared over the last few decades - typically because the "big bets" failed and they got swallowed up by some larger player who wants to add to their portfolio.
Add in all the biotechs that spend tens or hundreds of millions on R&D and get $0 in the end, biotech is far from an "easy" business.
I thought he'd be doing "this drug is for cats" wink wink and then people use it, but in retrospect a judge would see right through that.
I wonder if it would be significantly cheaper to go through regulatory approvals for a drug in another country, to the point where it would be worthwhile to relocate the company?
On the basis of what evidence.
But having read the whole article, he doesn't seem like a monster at all. If it works as planned it'll really help some cats.
There is no clean arrival for good, safe, effective medicine. A little gallows humor isn't hurting anyone.
This is the exact same issue vets face when they perform surgery on your cat, and it's the exact same issue that surgeons face when they perform surgery on you. The difference is that vets don't have to pay tons of money for malpractice insurance in case they get sued by the owner, which is one of the big reasons why veterinary surgery is so much cheaper (i.e. affordable to ordinary people) than human surgery.
..."in the USA". At a guess, I'd say it's the complete opposite in Europe with it's pesky human healthcare systems.
How many European doctors make more than $500k / year ? The average orthopedic makes roughly that (https://www.kaptest.com/study/mcat/doctor-salaries-by-specia...)
It's cheaper, but that has its price too.
To be fair. That's true of educated people in general, not just doctors.
Nowadays, older doctors (those who have served their 10 years) are moving from insurance-based to cash-based treatment because they demand much more than the "pricing tables" dictate - so there's a lot of doctors around you, but you can't go to them because the "public" insurance can be used only where they accept it, they never give you cash. The prices are very similar to US hospital quotes - in absolutes, not PPP. Meanwhile, we still have the "public" healthcare providers (these are corporations, but usually wholly or partially owned by political entities), but the quality is getting worse, they are unable to keep it stable, much less improve - not surprising since they rely on essentially forced labor.
I suspect scale may be a factor here.
I suppose this sentence is meant to be a little tongue in cheek, but a few of us at least do not find it funny.
Still: our society (rationally) does not devote the same resources to drug development for animals as it does for humans. And even protocols, dosing regimens, etc, for humans are not perfect. And even when the ideal protocol is chosen, some people still have a bad outcome by being an outlier.
Medicine is very imperfect; veterinary medicine is worse.
Wouldn't pet health insurance cover it?
I'm curious about this "pay later" arrangement - does it simply mean they'll invoice you on 30 day terms, or something else?
Not only is it common, but it's often assumed that it'll happen. It seems almost lucky when cats don't get it.
If an epidemic like that were affecting humans, a trillion dollars would be spent to fight it. But since it's cats, we just stay silent.
I wish there were more commercial incentive. I don't know how there would be, but I hope one day there will be.
Which is to say you're correct but it's not a hypothetical.
Only if it affected rich western countries. Poor fuckers of all ages from around equator are decimated daily and comparatively very little was done and its not great even now. Very easy and cheap to minimize exposure (ie mosquito nets), and completely reachable to eradicate for for maybe 70-80% of affected population. But I guess dying african/asian kid half around the world doesn't stir enough emotions these days.
PBS has a great documentary on it. https://www.pbs.org/video/dr-harvey-wiley-father-pure-food-s...
We can imagine lots of alternatives to what the FDA currently does - a partial approval pipeline immediately comes to mind in which the degree to which a drug is approved is commensurate to our confidence in the safety/efficacy of the drug. A different system could have different levels of approval on efficacy and safety. A different system could attempt to maximize lives saved (or utility years) and would look very different yet.
A proposal like you mentioned puts a lot of trust in the general public to be capable of making informed decisions based on detailed approval levels and risk profiles and not react to negative outcomes or side effects by blaming the FDA, pharmaceutical science, or the medical field.
It feels like putting that kind of complication into something as important and life affecting as pharmaceuticals is just asking for trouble when we live in a world where the grades for maple syrup needed to be simplified and large numbers of people think the President has direct control of gas prices.
Especially in the age of social media, it only takes a small increase in the number of people reacting illogically and lashing out to snowball, create loud counter narratives, and threaten the view of the FDA as a trusted authority and its ability to provide strong oversight. The result being increasing numbers of people harmed because they chose to avoid care or seek out sham alternative treatments.
We can already see these issues cropping up with regard to things like vaccines where factors like COVID vaccines being rolled out under early approval (an unfortunately necessary special case) has hurt public perception of the FDA.
The unhappy fact is that any approach that does not take into account the need to protect people from themselves, make efforts to minimize bad PR, and ensure the FDA appears as completely as possible to never make mistakes will result in an erosion of trust and even worse outcomes in the long term.
Regarding chronic idiopathic urticaria - cyclosporine was used in the past but now in the UK omalizumab is licensed for this and generally is more safe and effective.
If you found out one of the stray cats at unofficial “cat shelter” tested positive for FeLV and the person who runs the “cat shelter” seems oblivious to it, would you consider unethical to let the person continue run it? The FeLV virus is likely to spread among all the cats and result in a short life of suffering and illness.
How many cats are we talking about ?
Seems like a really long diversion from the original goals, doesn't it? "People have problem A and i want to test solution X for effectiveness" was the first principle, right? Now it sounds a lot like "we bought tons of this crap now we've gotta push it somehow"
Seems like the alternative here is to do nothing, so finding a productive but realistic path forward is a better alternative. I think it's clearly wrong to call running studies in animals "pushing it" on anyone.
If you have in-grown hairs, take Viagra once and they'll start coming out in a few hours on their own or with minimal mechanical force. The effect continues for a day or two so I am sure even the secondary metabolites might be somewhat active in inducing this effect.
We're trying to make it to profitability so we can get to the point where we can test the solution in humans who have neurodegeneration. When you're dealing with incredibly complex regulatory environments and millions of dollars in development costs, it's not always easy to make it from point A to point B. That's the point of this post.
"im making drugs for cats!" I shreik in my underwear as the FBI raids my derelict RV full of cat clozapine and TV dinner trays.
"im making drugs for cats" I calmly explain as i wheel a teetering trolly full of drain cleaner and paint thinner toward my car.
"im making drugs...for cats?" I shake my head as the prospect of tenure track seems to fade away.
'"im making drugs...for cats?" I shake my head as the prospect of tenure track seems to fade away.
"No, I'm not making drugs for cats."
"I'm not sure what you're trying to say."
"I'm trying to say that I'm not going to be a tenure-track professor."
"Oh."
I'm not sure what else to say. I know that I should be upset, or at least disappointed. But I'm not. I'm relieved.
I've been on the tenure track for six years, and I'm tired. I'm tired of the politics, the infighting, the backstabbing. I'm tired of the constant pressure to publish, to get grants, to bring in money. I'm tired of having to choose between my research and my teaching. I'm tired of feeling like I'm never good enough.
I'm not sure what I'm going to do next, but I know that I'm done with the tenure track. And that's OK.
"So, what are you going to do?"
"I'm not sure yet. But I'm open to suggestions."
"Well, you could always make drugs for cats."
I shake my head and laugh. "No, I don't think that's quite what I'm looking for."
But who knows? Maybe making drugs for cats is exactly what I need.
"In all seriousness, though, I wish you the best of luck in whatever you decide to do."
"Thank you. I appreciate that."
And with that, I walk away from the tenure track, and into the unknown.
Who knows what the future holds? But for now, I'm OK with not knowing.
I'm not sure what the future holds, but I'm open to whatever comes my way.
And that, to me, is the most exciting part.
(This story was originally published on The Professor Is In blog. It has been republished here with the author's permission.)'